Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth.
Towner RA, Smith N, Saunders D, Brown CA, Cai X, Ziegler J, Mallory S, Dozmorov MG, Coutinho De Souza P, Wiley G, Kim K, Kang S, Kong DS, Kim YT, Fung KM, Wren JD, Battiste J. Towner RA, et al. Among authors: ziegler j. Transl Oncol. 2019 Feb;12(2):320-335. doi: 10.1016/j.tranon.2018.10.002. Epub 2018 Nov 20. Transl Oncol. 2019. PMID: 30468988 Free PMC article.
OKN-007 decreases free radical levels in a preclinical F98 rat glioma model.
Coutinho de Souza P, Smith N, Atolagbe O, Ziegler J, Njoku C, Lerner M, Ehrenshaft M, Mason RP, Meek B, Plafker SM, Saunders D, Mamedova N, Towner RA. Coutinho de Souza P, et al. Among authors: ziegler j. Free Radic Biol Med. 2015 Oct;87:157-68. doi: 10.1016/j.freeradbiomed.2015.06.026. Epub 2015 Jun 26. Free Radic Biol Med. 2015. PMID: 26119786 Free PMC article.
AG488 as a therapy against gliomas.
Ziegler J, Bastian A, Lerner M, Bailey-Downs L, Saunders D, Smith N, Sutton J, Battiste JD, Ihnat MA, Gangjee A, Towner RA. Ziegler J, et al. Oncotarget. 2017 May 30;8(42):71833-71844. doi: 10.18632/oncotarget.18284. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 29069750 Free PMC article.
Preclinical Animal Studies of Intravesical Recombinant Human Proteoglycan 4 as a Novel Potential Therapy for Diseases Resulting From Increased Bladder Permeability.
Greenwood-Van Meerveld B, Mohammadi E, Latorre R, Truitt ER 3rd, Jay GD, Sullivan BD, Schmidt TA, Smith N, Saunders D, Ziegler J, Lerner M, Hurst R, Towner RA. Greenwood-Van Meerveld B, et al. Among authors: ziegler j. Urology. 2018 Jun;116:230.e1-230.e7. doi: 10.1016/j.urology.2018.02.034. Epub 2018 Mar 12. Urology. 2018. PMID: 29545038
Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model.
Zalles M, Smith N, Ziegler J, Saunders D, Remerowski S, Thomas L, Gulej R, Mamedova N, Lerner M, Fung KM, Chung J, Hwang K, Jin J, Wiley G, Brown C, Battiste J, Wren JD, Towner RA. Zalles M, et al. Among authors: ziegler j. J Cell Mol Med. 2020 Jan;24(2):1738-1749. doi: 10.1111/jcmm.14867. Epub 2019 Dec 21. J Cell Mol Med. 2020. PMID: 31863639 Free PMC article.
Peptidoglycan from Bacillus anthracis Inhibits Human Macrophage Efferocytosis in Part by Reducing Cell Surface Expression of MERTK and TIM-3.
Mytych JS, Pan Z, Lopez-Davis C, Redinger N, Lawrence C, Ziegler J, Popescu NI, James JA, Farris AD. Mytych JS, et al. Among authors: ziegler j. bioRxiv [Preprint]. 2023 Sep 30:2023.03.30.535001. doi: 10.1101/2023.03.30.535001. bioRxiv. 2023. Update in: Immunohorizons. 2024 Mar 1;8(3):269-280. doi: 10.4049/immunohorizons.2300109 PMID: 37066181 Free PMC article. Updated. Preprint.
1,171 results